Introduction
Since the beginning of the SARS-Cov-2 pandemic, it was realized that
cardiac involvement could occur, and elevated cardiac troponin I and the
presence of angiotensin-converting enzyme 2 receptors (required for the
entrance of the virus to cells) confirmed it. Moreover, mortality and
morbidity were higher in patients with cardiovascular involvement [1,
2]. Cardiac involvement includes several manifestations such as acute
myocardial injury, arrhythmia, myocarditis, cardiogenic shock, and heart
failure in varying severities [3]. Nevertheless, the knowledge of
the features of cardiac involvement and its mechanisms is scarce.
Myocarditis is a rare complication in COVID-19, which contributes to
rapid deterioration in patients.
Due to low incidence and failure to detect all cases with myocarditis,
understanding the mechanism and management is not complete [4].
Herein, we presented eleven cases of COVID-19 who are clinically
suspected to COVID-19 related myocarditis and their laboratory and
echocardiographic findings besides their following-up in three months.
Further prospective studies are necessary to recognize the underlying
mechanism, manifestations, and management of myocarditis in COVID-19
patients.